This content is in French.
Pomalidomide in relapsed/refractory multiple myeloma
5 mars 2024
In this study, researchers evaluated the efficacy and safety of pomalidomide in the combined treatment of relapsed/refractory multiple myeloma. In all, data from 31 clinical trials were reviewed, involving a total of 4,776 patients…
Sign in to read the rest
Reserved for healthcare professionals, free registration.
Scientific reference
Source(s) : Ying Luo et al. Pomalidomide combined with dexamethasone for the treatment of relapsed/refractory multiple myeloma: a systematic review and meta-analysis. Expert Rev Hematol. 2024 Feb 29.
View the source
